Ovid Therapeutics Inc (OVID) — Cash Flow Reinvestment Rate
Ovid Therapeutics Inc (OVID) has a Cash Flow Reinvestment Rate of 0.00x as of March 2021, reinvesting $23.03K (capex $11.51K plus investments $-11.51K) from operating cash flow of $160.90 Million. Check earnings quality score of Ovid Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ovid Therapeutics Inc Cash Flow Reinvestment Rate (2021–2021)
Historical reinvestment intensity for Ovid Therapeutics Inc across 1 annual periods. Explore long-term investment intensity of Ovid Therapeutics Inc to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Ovid Therapeutics Inc (2021–2021)
Year-by-year capital reinvestment analysis for Ovid Therapeutics Inc. For live market cap and broader valuation context, see market cap of Ovid Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.02x | $1.82 Million | $118.61 Million | $184.01K | — |